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Abstract. Mastoparan, a basic tetradecapeptide so- 
lated from wasp venom, is a novel mitogen for Swiss 
3T3 cells. This peptide induced DNA synthesis in syn- 
ergy with insulin in a concentration-dependent man- 
ner; half-maximum and maximum responses were 
achieved at 14 and 17 #M, respectively. Mastoparan 
also stimulated DNA synthesis in the presence of 
other growth promoting factors including bombesin, 
insulin-like growth factor-I, and platelet-derived 
growth factor. The synergistic mitogenic stimulation 
by mastoparan can be dissociated from activation of 
phospholipase C. Mastoparan did not stimulate phos- 
phoinositide breakdown, Ca 2+ mobilization or protein 
kinase C-mediated phosphorylation f a major cellular 
substrate or transmodulation f the epidermal growth 
factor receptor. In contrast, mastoparan stimulated ar- 
achidonic acid release, prostaglandin Fa production, 
and enhanced cAMP accumulation i the presence of 
forskolin. These responses were inhibited by prior 
treatment with pertussis toxin. Hence, mastoparan 
stimulates arachidonic acid release via a pertussis 
toxin-sensitive G protein in Swiss 3T3 cells. Arachi- 
donic acid, like mastoparan, stimulated DNA synthe- 
sis in the presence of insulin. The ability of mastopa- 
ran to stimulate mitogenesis was reduced by pertussis 
toxin treatment. These results demonstrate, for the 
first time, that mastoparan stimulates reinitiation of 
DNA synthesis in Swiss 3T3 cells and indicate that 
this peptide may be a useful probe to elucidate signal 
transduction mechanisms in mitogenesis. 
LUCIDATION of the molecular mechanisms leading to 
cell proliferation requires the identification of the sig- 
nal transduction pathways that, when activated, in- 
duce a mitogenic response. In this respect cultured fibro- 
blasts, such as murine 3T3 cells, have emerged as a model 
system. These cells cease to proliferate when they deplete 
the medium of its growth promoting activity and enter a
quiescent or nondividing state. However, such cells remain 
viable and can be stimulated to reinitiate DNA synthesis and 
cell division either by replenishing the medium with fresh se- 
rum or by the addition of polypeptide growth factors, neu- 
ropeptides and pharmacological gents in serum-free me- 
dium. Extensive analysis of early signaling events using this 
model has revealed the existence of multiple signal transduc- 
tion pathways that in synergy initiate a proliferative response 
(Rozengurt, 1986). The discovery of additional mitogens can 
provide novel approaches toexplore cellular signaling path- 
ways leading to cell proliferation. 
Mastoparan, an amphiphilic tetradecapeptide isolated from 
wasp venom, stimulates exocytosis ina variety of target cells 
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including mast (Hirai et al., 1979), chromaflin (Kuroda et 
al., 1980), pituitary (Carnoratto and Gradison, 1985; Kuri- 
hara et al., 1986), and pancreatic (Yokokawa et l., 1989) 
cells. The early events in the action of mastoparan i clude 
the breakdown of phosphoinositides and the mobilization of 
Ca 2+ from internal stores (Okano et al., 1985; Perianin and 
Snyderman, 1989; Tohkin et al., 1990). The mechanism by 
which mastoparan ctivates these signaling pathways does 
not involve specific membrane receptors (Aridor et al., 1990). 
Instead, mastoparan cts directly on G proteins reconstituted 
into phospholipid vesicles to stimulate guanine ucleotide 
exchange and GTP hydrolysis by a mechanism similar to that 
used by surface receptors (Higashijima et al., 1988, 1990; 
Mousli et al., 1990; Weingarten t al., 1990). This receptor- 
like activity of mastoparan could provide a novel probe to 
activate G proteins in intact cells. Indeed, some of the cellu- 
lar and molecular effects of mastoparan can be blocked by 
pertussis toxin (Aridor et al., 1990; Higashijima et al., 1987; 
Mousli et al., 1989; Saito et al., 1987; Yokokawa etal., 
1989), which ADP ribosylates and functionally inactivates 
a family of G proteins including transducin, Gi, and o (Gil-
man, 1987). In addition, mastoparan has been previously 
shown to interact with phospholipids (Higashijima et al. 
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1983) and to directly stimulate phospholipase A2 (PLA2) ~ 
activity leading to the generation of arachidonic acid (Ar- 
giolas and Pisano, 1983). Some of the early signals elicited 
by mastoparan in secretory cells, e.g., phosphoinositide break- 
down, Ca 2+ mobilization, and arachidonic acid release, have 
also been implicated in triggering cell proliferation by mito- 
genic neuropeptides and polypeptide growth factors in quies- 
cent cells (Rozengurt, 1986). As yet, however, it is not known 
which signal transduction pathways are activated by masto- 
paran in quiescent cells nor whether this peptide can act as 
a mitogen for these cells. 
In the present study we report hat mastoparan, atmicro- 
molar concentrations, stimulates reinitiation of DNA synthe- 
sis in Swiss 3T3 cells acting synergistically with insulin and 
other growth promoting factors. Before the stimulation of 
DNA synthesis, mastoparan i creases pertussis toxin-sensi- 
tive arachidonic a id release in the absence of inositol phos- 
phate accumulation. Thus, mastoparan provides a novel probe 
to elucidate signal transduction pathways in the mitogenic re- 
sponse. 
Materials and Methods 
Cell Culture 
Stock cultures of Swiss 3T3 cells were propagated as described previously 
(Rozengurt and Sinnett-Smith, 1983). For experimental purposes, cells 
were subcultured in 33- or 90-ram Nunc dishes with Dulbecco's modified 
Eagles medium (DMEM) supplemented with 10% fetal bovine serum and 
incubated in a humidified atmosphere of 10% CO2, 90% air at 37°C until 
they became confluent and quiescent (6-8 d). 
pH]Thymidine Incorporation Assay 
Determinations of DNA synthesis were p rformed as previously described 
(Dicker and Rozengurt, 1980). Briefly, cultures were washed twice with 
DMEM and incubated in DMEM/Waymouth's medium (l:l[vol/vol]) con- 
raining [3H]thymidine (1/~Ci/ml; 1/~M) and various additions as described 
in the experiments. After 40 h, the cultures were washed twice with PBS 
and incubated in 5 % trichloracetic acid for 30 rain at 4°C. Trichloracetic 
acid was then removed and the cultures washed twice with ethanol and ex- 
tracted in 1 ml of 2% Na2CO3, 0.1 M NaOH, 1% SDS. Incorporation was 
determined by scintillation counting in 10 ml of picofluor. 
Autoradiography of Labeled Nuclei 
Labeled nuclei were determined by autoradiography as described previ- 
ously (Dicker and Rozengurt, 1980). Briefly, cultures were washed twice 
with DMEM and incubated in 2 ml of DMEM/Waymouth's medium 
(l:l[vol/vol]) containing [3H]thymidine (5 t~Ci/ml) and the indicated fac- 
tors. After 40 h the medium was removed and the cultures were fixed in 
formol/saline (l:9[vol/vol]). The cultures were washed twice with Tris- 
saline, pH 7.4 at 4"C, fixed twice (for 5 and 2 min) with 5% trichloracetic 
acid at 4°C, and washed three times with 70% ethanol. Autoradiographic 
film was put on the cultures and developed after a 1-wk exposure. After 
staining with Giemsa, the labeled nuclei were counted. 
Determination ofTotal Inositol Phosphates 
Confluent and quiescent cells grown on 90-ram dishes were labeled with 
5 pCi/ml of v-myo-[3H]inositol f r 24 h at 37°C in conditioned medium. 
The cells were washed twice with DMEM preincubated for 20 rain in 
DMEM and then for 10 rain in DMEM containing 20 mM LiC1. Mastopao 
ran or bombesin were then added and the cells incubated for the indicated 
time. The incubations were stopped by rapidly replacing the medium with 
ice-cold 3% perchloric acid. After 30 min at 40C, the acid soluble xtracts 
1. Abbreviations used in this paper: IGF-I, insulin-like growth factor 1; 
PDBu, phorbol 12,13-dihutyrate; PGE2, prostaglandin E2; PLA2, phos- 
pholipase A2. 
were collected and neutralized (pH 7-8) with 2 M K2CO3, containing 10 
mM EDTA and 100 mM Hepes. Samples were analyzed for their content 
of total inositol phosphates byanion exchange chromatography using a Bio- 
Rad AG1X8 resin (Bio-Rad Laboratories, Richmond, CA) and elution with 
I M ammonium formate/0.1 M formic acid was performed as previously 
described (Berridge t al., 1983; Ntnberg and Rozangurt, 1988). 
80 K Phosphorylation 
Confluent and quiescent cells grown on 35-ram dishes were washed twice 
in phosphate-free DMEM and incubated for 5 h in 1 ml of the same medium 
containing 200 pCi 32p 1 . Pepddes were then added for various times. The 
reaction was stopped by removing the medium and rapidly washing the cul- 
ture twice with TBS. The cells were immediately extracted with 100/~1 of 
a solution containing 100 mM Tris-HCl, pH 6.9, 0.5% Triton X-100, 2 mM 
EGTA, 10 mM sodium fluoride, 50/~M PMSF, 3.5/zg/ml aprotmin for 
5 min at room temperature. The extract was heated at 100°C for 5 rain, cen- 
trifnged, and the supernatant was then mixed with an equal volume of 2× 
SDS sample buffer. One-dimensional SDS-PAGE was performed using 
7.5% (wt/vol) acrylamide and 0.1% (wt/vol) SDS (Laemmli, 1970). 
'~Ca ~ E~ux 
Quiescent cultures of Swiss 31"3 cells were equilibrated with 45Ca2+ by in- 
cubating them for 14-16 h in conditioned medium containing 5 ~,Ci/rrd 
45Ca 2+. Mastoparan or bombesin were added to the cultures and after 30 
rain of incubation at 37°C the extracellniar medium was removed and the 
cells rapidly washed seven times with DMEM containing 3 mM EGTA. 
Cellular 45Ca2+ was extracted with 0.1 N NaOH, 2% Na2CO3, 1% SDS, 
and determined by scintillation counting. 
~z~I-EGF Binding Assay 
Quiescent 3T3 cells were washed twice with DMEM at 37°C and incubated 
in a mixture of 1:1 DMEM and Waymouth's medium containing 50 mM 
Hepes, pH 7.0 at 37°C and factors as indicated. After 1 h, cells were then 
incubated at 4°C in PBS (pH 7.2) containing 25 mM Hepes and 0.5 ng/ml 
(110,000 cpm/ng) 125I-EGE After 2 h, cells were washed rapidly with 
PBS, extracted with 0.1 M NaOH containing 2% Na2CO3 and 1% SDS, 
and cell-associated radioactivity was determined in a gamma counter. 
Nonspecific binding was determined as cell-associated radioactivity in the 
presence of a 250-fold excess of unlabeled EGF as previously described 
(Zachary et ai., 1986). 
Arachidonic Acid Release 
Confluent and quiescent cells in 33-ram dishes were labeled for 14-16 h 
with 1 tzCi/rni [3H]arachidonic acid in conditioned medium. The cells 
were then washed 3 times with DMEM and incubated at 370C for 30 rain 
in 1 ml DMEM/Waymouth (1:1) containing mastoparan orbombesin as in- 
dicated. The medium was collected and centrifuged for 5 rain at 2,000 g 
to remove contaminating cellular debris and the level of radioactivity mea- 
sured by scintillation counting. 
Measurement ofProstaglandin E2 (PGE2) Release 
Cultures were washed twice with DMEM and incubated at 37°C for 1 h 
in the required conditions. After this time the medium was removed and 
stored at 4°C. All vessels used were made of polypropylene or siliconised 
glassware. Measurements of prostaglandin E2 (PGE2) were performed by 
radioimmunoassay using a 125I-PGE2 assay system. Aliquots of samples 
were diluted in assay buffer containing 0.9% NaC1, 0.01 M EDTA, 0.3% 
bovine 7-globulin, 0.005% Triton Xol00, 0.05% sodium azide, 25 mM 
phosphate buffer, pH 6.8. The samples were then bound to a rabbit anti- 
PGE2 antibody using ~25I-PGE2 as a competitive tracer for 16 h at 4°C. Af- 
ter this time the immune complexes were precipitated by the addition of 
16% polyethylene glycol, 0.05% sodium azide, and 50 m_M phosphate 
buffer, pH 6.8 for 30 rain at 4°C. Samples were centrifuged for 30 win at 
2,000 g and the supernatants removed. The resulting pellets were counted 
in a gamma counter (Beckman Instruments Inc., Palo Alto, CA). Additions 
of growth factors to the medium had no effect on the radioimmunoassay. 
Measurement ofcAMP 
Confluent and quiescent cells grown in 33-ram dishes were washed three 
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times in DMEM and incubated at 37°C for 1 h in 2 ml of the same medium 
in the presence of various factors. The medium was then rapidly replaced 
with 200 pl of 0.1 M HC1 and incubated for 20 min at 4°C. The solution 
was then diluted into 50 mM sodium acetate buffer, pH 5.8 and cAMP levels 
were determined using a commercial radioimmunoassay kit. The precipi- 
tated protein, remaining on the dish, was dissolved in 1 mi of 2% Na2CO3, 
0.1 M NaOH, and measured using the bicinchoninic acid reagent. 
Materials 
Mastoparan and pertussis toxin were obtained from Peninsula Laborato- 
ties, Inc. (Belmont, CA). Bombesin, EGF, bovine insulin, and phorbol- 
12,13-dibutyrate (PDBu) were fromSigma Chemical Co. (St. Louis, MO). 
Fetal bovine serum was from Gibco Laboratories (Grand Island, NY). 
C-sis recombinant PDGF, recombinant i sulin-like growth factor 1 (IGF-1), 
~z~I-EGF, [3I-I]thymidine, [32p]Pi (carrier free), DR-myo [3H]inositol, ~CaCI, 
[5, 6, 8, 9, 11, 12, 14, 15-3H]arachidonic ac d, and cAMP radioimmunoas- 
say kit were purchased from Amersham International (Amersham, UK). 
125I-PGE2 radioimmunoassay system was from New England Nuclear (Bos- 
ton, MA). Bicinchoninic acid reagent was from Pierce Chemical Co. (Rock- 
ford, IL). Forskolin was from Calbiochem-Behting Corp. (San Diego, CA). 
Dowex AG1-X8 (formate form) was obtained from Bio-Rad Laboratories, 
Richmond, CA). All other materials were of the purest grade commercially 
available. 
Results 
Mastoparan Induced DNA Synthesis in Synergy 
with Other Mitogens 
Initial experiments revealed that addition of 10-20/~M mas- 
toparan to quiescent cultures of Swiss 3T3 cells induced 
marked morphological changes and cytotoxic effects at the 
higher concentrations (25-30 #tM). To determine whether 
mastoparan can act as a mitogen for these cells, confluent 
and quiescent cultures were incubated in medium containing 
insulin and increasing concentrations of mastoparan. Cumu- 
80 
i 60 40 20 / i]t8o. 5o ,,o -~ _ I I I  
101520 0101517 
Mastoparan (pM) 
Figure 1. (Left) Dose response for the stimulation f DNA synthesis 
by mastoparan. Confluent and quiescent cultures of Swiss 3T3 cells 
were washed and incubated at 37°C in 2 ml DMEM/Waymouth 
medium containing 1 #Ci/ml [3H]thymidine and various concen- 
trations of mastoparan, in the absence (open circles) or in the pres- 
ence (closed circles) of insulin at 1#g/ml. After 40 h DNA synthe- 
sis was assessed by measuring the [~H]thymidine incorporated 
into acid precipitable material. Each point is the mean + SEM of 
eight determinations from four independent experiments expressed 
as a percentage of the incorporation induced by 10% FBS (4.5-6 x 
10 ~ cpm). (Right) Effect of mastoparan on DNA synthesis as- 
sessed by autoradiography. Cells were incubated at 37"C in 2 ml 
DMEM/Waymouth medium containing 5 #Ci/ml [3H]thymidine 
and various concentrations of mastoparan i  the presence of insulin 
at 1 #g/ml. 10% fetal bovine serum produced 95% labeled nuclei. 
The values are the mean + SEM of 10 different microscopic fields 
from 2 different dishes. 
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Figure 2. Stimulation of DNA synthesis by mastoparan in the pres- 
ence of various growth factors. (Left) Dose-response curve forthe 
stimulation of DNA synthesis by bombesin in the absence (open 
circles) or in the presence (closed circles) of 15/xM mastoparan. 
Each value is the mean of two determinations from one representa- 
tive experiment. (Right) Effect of mastoparan on IGF-1, PDGE 
PDBu, and EGF stimulation of DNA synthesis. Cells were in- 
cubated with different factors either in the absence (open bars) or
in the presence ( losed bars) of 15/~M mastoparan. The concentra- 
tions of IGF-1, PDGF, PDBu, and EGF were 20, 10, 100, and 10 
ng/ml, respectively. Each value is the mean oftwo determinations 
from one representative experiment. Similar results were obtained 
in two other independent experiments. 
lative [3H]thymidine incorporation was measured after 40 h 
of incubation. Fig. 1 (left), shows that mastoparan caused a
striking stimulation of DNA synthesis, in a narrow concen- 
tration range. Half of the maximum response was obtained 
at a concentration of 14 #M and the maximum effect was 
achieved at 17 #M. Mastoparan added without insulin did 
not induce any significant [3H]thymidine incorporation in 
Swiss 3T3 cells (Fig. 1, left). 
To assess whether mastoparan and insulin interact syner- 
gistically in eliciting initiation of DNA replication rather 
than in changing the specific activity of the [3H]thymidine 
precursor pool, quiescent cultures of Swiss 3T3 cells were 
treated with various concentrations of mastoparan i the 
presence of insulin and incorporation of pH]thymidine into 
DNA was quantified by autoradiography of labeled nuclei. 
As shown in Fig. 1 (right), mastoparan caused amarked en- 
hancement of the labeling index (from 10% in cultures 
treated with insulin alone to 78 % in cultures treated with in- 
sulin and 17 #M mastoparan). Thus, mastoparan a d insulin 
synergistically enhance the proportion of cells that enter into 
DNA synthesis. 
Mastoparan also stimulated DNA synthesis in the pres- 
ence of other growth promoting factors including bombesin 
(Fig. 2, left), IGF-1, PDGF, PDBu, or EGF (Fig. 2, right). 
The results hown in Figs. 1 and 2 demonstrate that mastopa- 
ran promotes ynergistic stimulation of DNA synthesis. 
Mastoparan Does Not Stimulate Phosphoinositide 
Breakdown, Ca t÷ Mobilization, or Protein Kinase C 
The mitogenic neuropeptides bombesin (Rozengurt and Sin- 
nett-Smith, 1983) and vasopressin (Rozengurt et al., 1979) 
bind to distinct receptors on 3T3 cells and induce rapid pro- 
duction of inositol phosphates (Heslop et al., 1986; Lopez- 
Rivas et al., 1987; N~nherg and Rozengurt, 1988), Ca 2+ 
mobilization leading to a decrease in cellular Ca 2÷ content 
and sustained activation of protein kinase C (Zachary et al., 
Gil et al. Mastoparan Stimulates Arachidonate Release and DNA Synthesis 945 
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Figure 3. Mastoparan does 
not stimulate phospholipase 
C. (Left) Mastoparan does not 
increase the formation of i o- 
sitol phosphates in Swiss 3T3 
cells. Quiescent cells grown 
on 90-mm dishes were loaded 
with 1 t~Ci/ml myo-[3H]inosi - 
tol and preincubated for 20 
min with 20 mM LiCI in 
DMEM, and then incubated 
for 10 min with different con- 
centrations of mastoparan or 
6 nM bombesin (B, cross- 
hatched bars). The acid-sol- 
uble inositol phosphates were 
determined as described in 
Materials and Methods. The 
results correspond to one rep- 
resentative experiment. Simi- 
lax results were obtained in two other independent experiments. (I set) Mastopaxan does not stimulate the phosphorylation of the Mr 
80,000 protein kinase C substrate (80 K). Quiescent cells labeled with 32pi were  treated with mastopaxan (+ i sulin) or 6 nM bombesin 
(B) for 10 min. The incubation was terminated and the samples analyzed by SDS-PAGE as described in Materials and Methods. (Right) 
Mastoparan has no effect on 4SCa2+ efflux from quiescent cultures of 3T3 cells. Quiescent 3T3 cells, preincubated with 45Ca2+ were in- 
cubated with different concentrations of mastopaxan (closed bars) or 6 nM bombesin (cross-hatched bar) for 10 min in the presence of 
the isotope. The radioactive medium was aspirated and the cultures were rapidly washed seven times with 2 ml of 3 mM EGTA-containing 
DMEM at 37°C. The radioactivity left in the cells was extracted and measured as d scribed in Materials and Methods. T e values represent 
the mean + SEM of four to five determinations from two independent experiments. 
1986; Rodriguez-Pena and Rozengurt, 1986) via a G protein- 
linked transduction pathway (Erusalimsky et al., 1988; Erusa- 
limsky and Rozengurt, 1989; SinneR-Smith et al., 1990; Coffer 
et al., 1990). Mastoparan is known to stimulate Ins(1,4,5)P3 
synthesis and Ca 2+ mobilization in certain target cells (Ok- 
ano et al., 1985; Perianin and Snyderman, 1989; Tohkin 
et al., 1990), presumably through direct activation of a G 
protein coupled to phospholipase C. Hence, we determined 
whether mastoparan-induced mitogenesis was mediated by 
a similar signaling pathway. Fig. 3 shows that mastoparan, 
at concentrations that induced mitogenesis, neither increased 
inositol phosphate production n r caused Ca 2+ mobilization 
from intracellular stores, as measured in *sCa2+-labeled cells. 
Similar results were obtained when the cells were incubated 
with 17 #M mastoparan for 0.5, 1, 2, or 4 h (results not 
shown). 
We next examined whether mastoparan treatment increases 
the phosphorylation f the 80 K protein, a major substrate 
Table L Effect of Various Concentrations ofMastoparan 
on the Binding of mI-EGF 
EGF binding 
Addition (percent of control) 
None 100 
Bombesin (6 nM) 19 + 2 
Mastoparan (15 #M) 102 + 7 
Mastoparan (17 tzM) 98 + 8 
Mastoparan (20 tiM) 94 + 14 
Quiescent Swiss 3T3 cells were incubated for 1 h at 37°C in binding medium 
containing bombesin (6 nM) or various concentrations of mastoparan. After 
this time, the binding of nSI-EGF to intact cells was measured as described in 
Materials and Methods. The results are expressed as percentage of the control 
and correspond to the mean 5: SEM of six independent experiments. 
of protein kinase C in 3T3 cells (Rozengurt et al., 1983; 
Rodriguez-Pena and Rozengurt, 1986a; Erusalimsky et al., 
1988). Mastoparan added for 10 min either in the absence 
or presence of insulin failed to increase 80 K phosphoryla- 
tion (Fig. 3, inset). Similar results were obtained when the 
cells were incubated with mastoparan at 17 #M for 30 min 
(results not shown). Activation of protein kinase C is known 
to reduce the affinity of the EGF receptor for its ligand (Zach- 
ary et al., 1986). Table I shows that mastoparan, atconcen- 
trations up to 20 #M, did not alter 125I-EGF binding to Swiss 
3T3 cells. In contrast, under identical experimental condi- 
tions, bombesin stimulated inositol phosphate accumulation, 
decreased Ca 2+ content, promoted 80 K phosphorylation, and 
Table II. Protein Kinase C Downregulafion Does Not 
Affect Mastoparan-induced DNA Synthesis 
PDBu 
Additions pretreatment DNA synthesis 
% 
Insul in - 6 + 1 
+ 8+1 
Insul in + mastoparan - 55 + 9 
+ 61+5 
Insul in + PDBu - 93 + 2 
+ 12+1 
Quiescent cells were incubated for 40 h in their own conditioned medium, in 
the absence orpresence of PDBu (400 ng/ml). At this time, cells were washed 
with DMEM and incubated as described in Materials and Methods for 
[3H]thymidine incorporation i the presence of 1 #g/ml insulin and either 17 
p.M mastoparan or 100 ng/ml PDBu. Results are expressed as a percentage of 
the incorporation induced by 10% fetal bovine serum and correspond to the 
means ± SEM of three independent experiments with incubations in duplicate. 
The Journal of Cell Biology, Volume 113, 1991 946 
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Figure 4. Effect of mastoparan 
on arachidonic acid release, 
PGEz production, and cAMP 
accumulation i control and 
pertussis toxin-treated cells. 
(A) Arachidonic acid release. 
Quiescent cells were labeled 
for 16 h with 1/zCi/ml [~H]ar- 
achidonic acid preincubated in 
DMEM/Waymouth medium 
either in the absence (open 
bars) or presence (closed bars) 
of 100 ng/ml pertussis toxin 
for 3 h. At this time the cells 
were incubated with fresh me- 
dium containing mastoparan 
at the indicated concentrations 
for 30 min. After this time the 
medium was removed and cen- 
trifuged for 5 min at 2,000 g 
to remove contaminating cel- 
lular debris and the superna- 
tant was counted directly o 
monitor arachidonic acid re- 
lease. (B) PGE2 release. Qui- 
escent ceils were preincubated 
in DMEM/Waymouth either 
in the absence (open bars) or 
presence of 100 ng/ml pertussis toxin (closed bars) for 3 h. At this 
time the cells were incubated with fresh medium containing mas- 
toparan at the indicated concentrations for 1 h. After this time the 
medium was removed and stored at 4°C and PGF_~ was measured 
as described in Materials and Methods. (C) cAMP accumulation. 
Cultures were preincubated in DMEM/Waymouth medium con- 
taining either 100 ng/ml pertussis toxin (closed bars) or no addition 
(open bars) for 3 h. At this time the cells were incubated with fresh 
medium containing various concentrations of mastoparan in the 
presence of 25 #M forskolin. After 1 h the cellular content of cAMP 
was measured. The values correspond to the mean + SEM of three 
determinations from one representative experiment. 
inhibited ~SI-EGF binding in parallel cultures (Fig. 3; Ta- 
ble I). Furthermore, down regulation of protein kinase C by 
prolonged exposure to PDBu (Rodriguez-Pena and Rozen- 
gurt, 1984) did not prevent the mitogenic effect of mastopa- 
ran in the presence of insulin (Table U). Collectively, these 
results indicate that he mitogenic activity of mastoparan can 
be dissociated from activation of phospholipase C.
Mastoparan Stimulates Arachidonic Acid Release 
It is known that mastoparan stimulates PLA2 activity from 
a variety of sources presumably by rendering the substrate 
more susceptible to PLA2 action (Argiolas and Pisano, 1983). 
We therefore xamined the effect of mastoparan on arachi- 
onic acid release in 3"1"3 cells. 
Fig. 4 A shows that rnastoparan i duces adose-dependent 
release of radioactivity into the medium from quiescent cul- 
tures prelabeled with [3H]arachidonic acid. Since arachi- 
donic acid is a major precursor for the synthesis of E-type 
prostaglandins, we examined the effect of mastoparan o  the 
production of PGF,2. As shown in Fig. 4 B, mastoparan 
caused amarked and dose-dependent release of PGFa from 
quiescent cultures of Swiss 3T3 cells. 
In previous studies, bombesin (Millar and Rozengurt, 
1988) and PDGF (Rozengurt et al., 1983b) have been shown 
to enhance cAMP accumulation via a cyclooxygenase-de- 
pendent pathway. Although mastoparan did not increase the 
basal level of cellular cAMP, mastoparan enhanced cAMP 
accumulation i  the presence of either the phosphodiesterase 
inhibitor IBMX (Table HI) or the diterpene forskolin, a direct 
activator of adenylate cyclase (Fig. 4 C). The cyclooxyge- 
nase inhibitor indomethacin blocked mastoparan-stimulated 
production of PGFa (Table IV) and inhibited the enhance- 
ment of cAMP accumulation by the peptide in the presence 
of forskolin (results not shown). 
Pertussis toxin is known to ADP-ribosylate G proteins 
thereby blocking their function in receptor-mediated signal 
transduction (Ui, 1990). A salient feature shown in Fig. 4 
is that arachidonic acid release, PGF_,2 output, and enhance- 
ment of cAMP accumulation i duced by mastoparan were 
inhibited markedly b  prior treatment (3 h) with 100 ng/ml 
pertussis toxin. These findings strongly suggest that masto- 
paran increases arachidonic acid release via a pertussis toxin- 
sensitive G protein. 
Arachidonic Acid Release as a Mitogenic Signal in 
Mastoparan Action 
Stimulation of a proliferative r sponse in 3T3 cells requires 
the synergistic nteraction of multiple distinct signaling path- 
ways (Rozengurt, 1986). The preceding results raise the pos- 
sibility that stimulation of arachidonic acid release by mas- 
toparan may constitute a synergistic mitogenic signal. This 
possibility predicts that: (a) externally applied arachidonic 
Table IlL Effect of Mastoparan on cAMP Accumulation 
in the Presence oflBMX 
Addition cAMP 
(pmol/mg protein) 
None 3.6 4- 0.3 
Mastoparan 4.3 4- 0.1 
IBMX 5.1 4- 0.6 
Mastoparan + IBMX 12.7 4- 1.1 
Quiescent Swiss 3T3 cells were incubated for 1 h at 370C in DMEM containing 
mastoparan (17 t~M), 50 I~M IBMX, or both. After this time the cellular con- 
tent of cAMP was measured as described in Materials and Methods. The 
cAMP content of cultures incubated for 4 h (instead of 1 h) without or with 
mastoparan was 4.9 5- 0.3 and 5.4 5- 0.5, respectively. The results cor- 
respond to the mean + SEM of three determinations. 
Table IV. Effect of lndomethacin on Mastoparan-induced 
PGE2 Release 
Indomethacin 
Addition (1 #M) PGEa 
ng/ral 
None - 1.6 4- 0.3 
Mastoparan - 22.0 + 2.0 
None + 1.3 4- 0.1 
Mastoparan + 2.6 + 0.2 
Quiescent Swiss 3T3 cells were incubated for 1 h at 37"C in DMEM or 
DMEM plus 20 #M mastoparan i  the absence ( - )  or presence (+) of I #M 
indomethacin. After this time, PGE2 release was measured as described in 
Materials and Methods. The values correspond to the mean + SEM of three 
determinations. 
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Figure 5. (A) Dose response for the stimulation f DNA synthesis 
by arachidonic acid. Confluent and quiescent cultures ofthese cells 
were exposed to 2 ml of DMEM/Waymouth medium containing 
0.1% fatty acid-free BSA. 1 ftCi/ml [3H]thymidine, and various 
concentrations of arachidonic acid, either in the absence (op  cir-
cles) or in the presence of 1 #g/ml insulin (closed circles). (B) 
Effect of pertussis toxin pretreatment on mastoparan stimulation of 
DNA synthesis. Cultures were preincubated in DMEM/Waymouth 
medium either in the absence (open circles) or in the presence of 
100 ng/ml pertussis toxin (closed circles) for 3 h. At this time me- 
dium was removed and the incubation continued in DMEM/Way- 
mouth medium containing 1 #Ci/ml [3H]thymidine, 1 #g/ml insu- 
lin, and different concentrations of mastoparan either in the ab- 
sence (open circles) or in the presence (closed circles) of 100 ng/ml 
pertussis toxin. After 40 h DNA synthesis was assessed by measur- 
ing the incorporation of pH]thymidine into precipitable material 
as described in Materials and Methods. The results represent the 
mean of two different dishes of one representative experiment ex- 
pressed as a percentage of th incorporation induced by 10%FBS. 
acid, like mastoparan, will act synergistically with insulin to 
induce mitogenesis in 3T3 ceils; (b) pertussis toxin treatment 
should reduce the mitogenlc response induced by mastopa- 
ran; and (c) agents that induce cAMP accumulation i the 
presence of mastoparan, such as IBMX or forskolin, should 
potentiate DNA synthesis induced by mastoparan and insu- 
lin. The experiments presented in Figs. 5 and 6 were de- 
signed to test the predictions. 
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Figure 6. Effect of forskolin or 
IBMX on mastoparan stimu- 
lation of DNA synthesis n 
Swiss 3T3 ceils. Confluent 
and quiescent cultures of these 
cells were exposed to 2 ml of 
DMEM/Waymonth medium 
containing 1 #Ci/ml [3H]thy- 
midine, 1 #g/ml insulin, and 
various concentrations f mas- 
toparan either in the absence 
(open circles) or presence of 
forskolin at 5 #M (closed cir- 
cles, top) or IBMX at 50 #M 
(closed circles, bottom). After 
40 h DNA synthesis was as- 
sessed by measuring the level 
of [3H]thymidine incorporated 
into acid precipitable mate- 
rial. Each point is the mean of 
two determinations from one 
representative experiment ex- 
pressed as a percentage of 
the incorporation induced by 
10% FBS. 
Cultures of Swiss 3T3 cells were exposed to various con- 
centrations ofarachidonic acid in the absence or presence of 
insulin and assayed for [3I-I]thymidine incorporation as an 
indicator of DNA synthesis. Arachidonic acid potently syn- 
ergized with insulin to stimulate DNA synthesis (Fig. 5 A). 
As reported recently (Millar and Rozengurt, 1990), arachi- 
donic acid did not induce DNA synthesis in the absence of 
other factors. Furthermore, the ability of mastoparan to 
stimulate [3H]thymidine incorporation i  the presence of 
insulin was markedly reduced by pertussis toxin treatment, 
especially at lower concentrations of peptide (Fig. 5 B). 
Mastoparan stimulates PGF~ release and, in the presence 
of forskolin or a phosphodiesterase inhibitor, elevates cAMP 
levels which is known as a mitogenic signal for Swiss 3T3 
cells (Rozengurt et al., 1981, 1983; Rozengurt, 1986). Fig. 
6 shows that addition of either forskolin or IBMX strikingly 
potentiated the induction of DNA synthesis by various con- 
centrations of mastoparan i the presence of insulin. These 
potentiating effects were markedly reduced by prior treat- 
ment with pertussis toxin (results not shown). 
Discussion 
The present results demonstrate hat mastoparan is a novel 
mitogen for Swiss 3T3 cells. The peptide, at micromolar 
concentrations, timulates reinitiation of DNA synthesis 
only in synergistic ombinations, particularly with insulin 
and IGF-1. Furthermore, mastoparan potentiates the mito- 
genic response licited by bombesin or PDGF. Since its iso- 
lation from wasp venom as a mast cell degranulating factor 
(Hirai et al., 1979), mastoparan has been shown to induce 
short-term exocytosis n numerous secretory cell types (Hi- 
rai et al., 1979; Kuroda et al., 1980; Camoratto and Grandi- 
son, 1985; Kurihara et al., 1986; Yokokawa et al., 1989). 
To our knowledge, this is the first time that mastoparan has 
been shown to stimulate reinitiation of DNA synthesis n any 
target cell. 
The mechanism(s) ofaction of mastoparan is attracting in- 
terest because this peptide may mimic the receptor do- 
main(s) that directly activates G proteins either in recon- 
stituted phospholipid vesicles or in intact cells (Higashijima 
et al., 1988, 1990; Mousli et al., 1990; Weingarten et al., 
1990). It is known that mastoparan regulates the activity of 
purified G proteins (e.g., Go and Gi) over a narrow range of 
concentration (Higashijima et al., 1990). In the present 
study we showed that mastoparan stimulation of DNA syn- 
thesis in 3T3 cells was steeply dose-dependent. The coopera- 
tivity of these dose responses suggests hat several molecules 
of mastoparan bound to phospholipid brayers may be re- 
quired to activate G protein activity either in vitro or in intact 
cells. 
In certain cell types, mastoparan stimulates polyphospho- 
inositide-specific phospholipase C (Okano et al., 1985; Peri- 
anin and Snyderman, 1989; Tohkin et al., 1990), leading to 
Ca 2+ mobilization and activation of protein kinas¢ C, a path- 
way known to be regulated by a G protein and involved in 
mitogenic signaling by neuropeptides and growth factors 
(Rozengurt, 1986). The results presented here demonstrate 
that this is not the case in Swiss 3"I"3 cells as judged by mea- 
surements of inositol phosphate accumulation, Ca 2+ mobili- 
zation, and protein kinase C-mediated phosphorylation f 
the 80 K substrate and EGF receptor transmodulation. Fur- 
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thermore, downregulation of protein kinase C that blocks 
mitogenic signaling via this pathway (Rodriguez-Pena and 
Rozengurt, 1984; Rozengurt et al., 1984) did not prevent the 
mitogenic response initiated by mastoparan. From these re- 
suits we conclude that mastoparan stimulation of DNA syn- 
thesis can be dissociated from phospholipase C activation 
and consequently, that the peptide stimulates a different sig- 
naling pathway. 
In the present study we demonstrate hat mastoparan i - 
duces a striking release of arachidonic acid and its cyclo- 
oxygenase metabolite PGFa into the medium. Recent evi- 
dence has indicated that the liberation of arachidonic acid 
and its conversion toeicosanoids constitutes one of the early 
mitogenic signals induced by bombesin i  3"1"3 cells (Millar 
and Rozengurt, 1990). It is also noteworthy that the PDGF 
AA and PDGF BB homodimers that, like bombesin, stimu- 
late reinitiation of DNA synthesis in the absence of other 
growth promoting factors induce a large and sustained re- 
lease of arachidonic acid in Swiss 3T3 cells (Mehmet et al., 
1990). The results presented here with mastoparan lso sup- 
port the conclusion that arachidonic acid release contributes 
to mitogenic signal transduction. However, sincethe inhibi- 
tion of arachidonic acid release by pertussis toxin treatment 
was more pronounced than the inhibition of [3H]thymidine 
incorporation, we cannot exclude the possibility that mas- 
toparan induces cellular DNA synthesis through additional 
signaling pathways. 
Arachidonic acid may be liberated as a result of either di- 
rect action of PLA2 or by indirect routes involving the re- 
lease of arachidonic acid from diacylglycerol by diglyceride 
lipase. Arachidonic a id-containing diacylglycerol is one of 
the most potent physiological activators of protein kinase C 
(Nishizuka, 1986). Here we showed that mastoparan stimu- 
lates arachidonic a id release without causing concomitant 
inositol phosphate accumulation or activation of protein ki- 
nase C. In contrast, vasopressin which stimulates phospholi- 
pase C-mediated phosphoinositide breakdown, diacylgly- 
cerol formation, and activates protein kinase C does not 
cause sustained stimulation of arachidonic acid release from 
Swiss 3T3 cells (Millar and Rozengurt, 1990). Hence, ara- 
chidonic acid release can be separated from diacylglycerol 
formation in these cells. We conclude that mastoparan stim- 
ulates arachidonic acid release from 3T3 cells through acti- 
vation of PLA2. 
Previous tudies demonstrated that mastoparan stimulates 
the activity of purified PLA2 reconstituted into phospho- 
lipid vesicles, presumably interacting with the phospholipids 
and rendering them more susceptible to PLA2 action (Ar- 
giolas and Pisano, 1983). Our results using pertussis toxin 
that catalyses ADP-ribosylation of the c~ subunits of G pro- 
teins (Ui, 1990) suggest that in 3T3 cells mastoparan stimu- 
lates PLA2 activity via n entirely different mechanism. 
Treatment with pertussis toxin of 3T3 ceils markedly attenu- 
ated the ability of mastoparan tostimulate arachidonic acid 
release, PGE2 production, and enhancement of cAMP ac- 
cumulation. These findings indicate that m stoparan stimu- 
lates arachidonic a id release via a pertussis toxin-sensitive 
G protein, rather than by interaction with cellular phospho- 
lipids. In contrast, pertussis toxin does not interfere with 
phospholipase C activation by either bombesin (Zachary et 
al., 1987) or vasopressin (Erusalimsky and Rozengurt, 1989) 
in Swiss 3T3 cells. Recently, the possibility has been raised 
that PLA~ is directly regulated by a pertussis toxin-sensi- 
tive G protein and that separate G proteins transduce re- 
ceptor-mediated activation of PLA~ and phospholipase C 
(Axelrod, 1990). In this context, the results presented here 
suggest that mastoparan selectively stimulates a perttissis 
toxin-sensitive G protein that regulates PLA2 activity in in- 
tact 3T3 cells. In conclusion, mastoparan should be a useful 
probe to elucidate G-protein coupled signal transduction 
pathways in the mitogenic response. 
Received for publication 13 November 1990 and in revised form 12 Febru- 
ary 1991. 
References 
Argiolas, A., and J. J. Pisano. 1983. Facilitation f pbospholipase A2activity 
by mastoparans, a new class of mast cell degranulating peptides from wasp 
venom. J. Biol. Chem. 258:13697-13702. 
Aridor, M., L. Tranb, and R. Sagi-Eisenberg. 1990. Exocytosis in mast cells 
by basic secretagogues: vidence for direct action of GTP-binding proteins. 
J. Cell Biol. 111:909-917. 
Axelrod, J. 1990. Receptor-mediated activation of phospholipase As and ara- 
chidonic acid release in signal transduction. Biochem. Soc. Trans. 18:503- 
507. 
Berridge, M. J., R. M. C. Dawson, C. P. Downes, J. P. Heslop, and R. F. 
Irvine. 1983. Changes in the levels of inositol phosphates after agonist- 
dependent hydrolysis of membrane phosphoinositides. Biochem. J. 212: 
473--482. 
Camoratto, A. M., and L. Grandison. 1985. Evidence supporting a correlation 
between arachidonic acid release and prolactin secretion from GH3 cells. 
Endocrinology. 116:1506-1513. 
Coffer, A., I. Fabregat, J. Sirmett-Smith, and E. Rozengurt. 1990. Solubiliza- 
tion of the bombesin receptor from Swiss 3T3 cell membranes: functional 
association toa guanine nucleotide r gulatory protein. FEBS (Fed. Eur. Bio- 
chem. Soc.) Lett. 263:80-84. 
Dicker, P., and E. Rozengurt. 1980. Phorbol esters and vasopressin stimulate 
DNA synthesis by a common mechanism. Nature (Lond.). 287:607-612. 
Emsalimsky, J. D., and E. Rozengurt. 1989. Vasopressin rapidly stimulates 
protein kinase C in digitonin-permeabilized Swiss 3T3 cells: involvement of
a permssis toxin-insensitive guanine nucleotide binding protein. J. Cell. 
Physiol. 141:253-261. 
Erusalimsky, J. D., I. Friedberg, and E. Rozengurt. 1988. Bombesin, diacyl- 
glycerols and phorbol esters rapidly stimulate the phosphorylation f an Mr 
= 80,000 protein kinase C substrate in permeabilized 3T3 ceils: effect of 
guanine nucleotides. J. Biol. Chem. 263:19188-19194. 
Gilman, A. G. 1987. G proteins: transducers of receptor-generated signals. 
Annu. Rev. Biochem. 56:615-649. 
Heslop, J. P., D. M. Blakeley, K. D. Brown, R. F. Irvine, and M. J. Berridge. 
1986. Effects ofbombesin and insulin on inositol (1,3,4)trisphosphate forma- 
tion in Swiss 3T3 cells. Cell. 47:703-709. 
Higashijima, T., K. Wakamatsu, M. Takemitsu, M. Fujino, T. Nakajima, and 
T. Miyazawa. 1983. Conformational change of mastoparan from wasp 
venom on binding with phospholipid membrane. FEBS (Fed. Eur. Biochem. 
Soc.) Lett. 152:227-232. 
Higashijima, T., S. Uzu, T. Nakajima, and T. Miyazawa. 1987. Mechanism 
of histamine release by mastoparan. I  Peptide Chemistry 1986. T. Miya- 
zawa, editor. Protein Research Foundation, Osaka, Japan. 75-78. 
Higashijima, T., S. Uzu, T. Nakajima, and E. M. Ross. 1988. Mastoparan, 
a peptide toxin from wasp venom, mimics receptors by activating GTP- 
binding regulatory proteins (G proteins). J BioL Chem. 263:6491-6494. 
Higashijima, T., J. Burnier, and E. M. Ross. 1990. Regulation of G~ and Go 
by mastoparan, related amphiphilic peptides, and hydrophobic amines. J. 
Biol. Chem. 265:14176-14186. 
Hirai, Y., T. H. Yasuhara, T. Nakajima, M. Fujino, and C. Kitada. 1979. A 
new mast cell degranulating peptide "mastoparan" i  the venom of Fespula 
lewisii. Chem. Pharm. Bull. (Tokyo). 27:1942-1944. 
Kurihara, H., K. Kitajima, T. Senda, H. Fujita, and T. Nakajima. 1986. MUl- 
tigranular exocytosis nduced by phospholipase A2-activators, melittin and 
mastoparan, i  rat anterior pituitary cells. Cell Tissue Res. 243:311-316. 
Kuroda, Y., M. Yoshioka, K. Kamakura, K. Kobayashi, and T. Nakajima. 
1980. Effects of peptides on the release of catecholamines and adenine nu- 
cleotides from cultures adrenal chromaffin ceils. Proc. Japan Acad. 56: 
660-664. 
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of 
the head of bacteriophage "1"4. Nature (Lond.). 227:680-685. 
Lopez-Rivas, A., S. A. Mendoza, E. N/lnberg, J. Sinnett-Smith, and E. 
Rozengurt. 1987. The Ca2+-mobilizing actions of platelet-derived growth 
factor differ from those of bombesin and vasopressin in Swiss 3T3 cells. 
Proc. Natl. Acad. Sci. USA. 84:5768-5772. 
Mehmet, H., E. N~mberg, W. Lehmann, M. J. Murray, and E. Rozengurt. 
Gil et al. Mastoparan Stimulates Arachidonate Release and DNA Synthesis 949 
 o
n
 M
ay 8, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published May 15, 1991
1990. Early signals in the mitogenic response of Swiss 3T3 cells: a compara- 
tive study of purified PDGF homodimers. Growth Factors. 3:83-95. 
Millar, J. B. A., and E. Rozengurt. 1988. Bombesin enhancerr~nt of cAMP 
accumulation i  Swiss 3T3 ceils: evidence of a dual mechanism of action. 
J. Cell. Physiol. 137:214-222. 
Millar, J. B. A., and E. Rozengurt. 1990. Arachidonic acid release by bombe- 
sin: a novel post-receptor target for heterologous mitogenic desensitization. 
J. BioL Chem. 265:19973-19979. 
Mousli, M., C. Brenner, J. L. Bueb, E. Tschirhart, J. P. Gies, and Y. Landry. 
1989. Activation of rat peritoneal mast cells by substance P and mastuparan. 
J. Pharm. Exp. Ther. 250:329-335. 
Mousli, M., C. Brenner, Y. Landry, J. Bockaert, and B. Rouot. 1990. Direct 
activation of GTP-binding regulatory proteins (G-proteins) by substance P 
and compound 48/80. FEBS (Fed. Eur. Biochem. Soc.) Lett. 259:260-262. 
N~mberg, E., and E. Rozengurt. 1988. Temporal relationship between i ositol 
polyphosphate formation and increases in cytosolic Ca 2+ in quiescent 3T3 
cells stimulated by platelet-derived growth factor, bombesin and vasopres- 
sin. EMBO (Fur. Mol. Biol. Organ.) J. 7:2741-2747. 
Nishizuka, Y. 1986. Studies and perspectives of protein kinase C. Science. 
233:305-312. 
Okano, Y., H. Takagi, T. Tohmatsu, S. Nakashima, Y. Kuroda, K. Saitio, and 
Y. Nozawa. 1985. A wasp venom mastoparan-induced polyphosphoinositide 
breakdown i rat peritoneal mast cells. FEBS (Fed. Fur. Biochem. Soc. ) Lett. 
188: 363 - 66. 
Perianin, A., and R. Snyderman. 1989. Mastoparan, a wasp venom pepdde, 
identifies two discrete mechanisms for elevating cytosolic alcium and inosi- 
tel trisphosphates in human polymorphonuclear leukocytes. J lmmunol. 
143:1669-1673. 
Rodriguez-Pena, A., and E. Rozengurt. 1984. Disappearance of Ca2+-sensi - 
tive, phospholipid-dependent protein kinase activity in pborbol ester-treated 
3T3 cells. Biochem. Biophys. Res. Commun. 120:1053-1059. 
Rodriguez-Pena, A., and E. Rozengurt. 1986a. Phosphorylation f an acidic 
Mr = 80,000 cellular protein in cell-free system and intact Swiss 3T3 cells: 
a specific marker of protein kinase C activity. EMBO (Fur. MoL BioL Or- 
gan.) J. 5:77-83. 
Rodriguez-Pena, A., and E. Rozengurt. 1986b. Vasopressin rapidly stimulated 
protein kinase C in quiescent Swiss 3T3 cells. J. Cell Physiol. 129:124-130. 
Rozengurt, E. 1986. Early signals in the mitogenic response. Science (Wash. 
DC). 234:161-166. 
Rozengurt, E., and J. Sinnett-Smith. 1983. Bombesin stimulation ofDNA syn- 
thesis and cell division in cultures of Swiss 3T3 ceils. Prec. Natl. Acad. Sci. 
USA. 80:2936-2940. 
Rozengurt, E., A. Legg, and P. Pettican. 1979. Vasopressin stimulation of3T3 
cell growth. Prec. Natl. Acad. Sci. USA. 76:1284-1287. 
Rozengurt, E., A. Legg, G. Strang, and N. Courtenay-Luck. t981. Cyclic 
AMP: a mitogunic signal for Swiss 3T3 cells. Prec. Natl. Acad. Sci. USA. 
78:4392-4396. 
Rozengurt, E., M. Rodriguez-Pena, nd K. A. Smith. 1983a. Phorbol esters, 
phospholipase C, and growth factors rapidly stimulate the phosphorylation 
of a Mr 80,000 protein in intact quiescent 3T3 cells. Prec. Natl. Acad. Sci. 
USA. 80:7244-7248. 
Rozengurt, E., P. Stroobant, M. D. Waterfield, T. F. Deuel, and M. Keehan. 
1983b. Platelet-derived growth factor elicits cyclic AMP accumulation i  
Swiss 3T3 cells: Role of prostaglandin production. Cell. 34:265-272. 
Rozengurt, E., A. Rodriguez-Pena, M. Coombs, and J. Sinnett-Smith. 1984. 
Diaeylglycerol stimulates DNA and cell division in mouse 3T3 cells: role 
of Ca~-sensitive, phospbolipid-dependent protein kinase. Prec. Natl. Acad. 
Sci. USA. 81:5748-5752. 
Rozengurt, E., M. Murray, I. Zachary, and M. Collins. 1987. Protein kinase 
C activation enhances cAMP accumulation in Swiss 3T3 cells: inhibition by 
pertussis toxin. Prec. Natl. Acad. Sci. USA. 84:2282-2286. 
Salto, H., F. Okajima, T. F. P. Molski, R. I. Sha'afi, M. Ui, andT. Ishizaka. 
1987. Effects of ADP-ribosylation ofGTP-binding protein by permssis-toxin 
on immunoglobulin E-dependent and independent histamine rel ase from 
mast ceils and basophils. J lmmunol. 138:3927-3934. 
Tohkin, M., T. Yagami, and T. Matsubara. 1990. Mastoparan, a peptide toxin 
from wasp venom, stimulates glycogenolysis mediated by an increase of the 
cytosolic free Ca ~+ concentration but not by an increase of cAMP in rat he- 
patocytes. FEBS (Fed. Fur. Biochem. Soc.) Left. 260:179-182. 
Ui, M. 1990. Pertussis toxin as a valuable probe for G-protein involvement in
signal transduction. I  ADP-ribosylating Toxins and G Proteins. J Moss and 
M. Vaughan, editors. American Society for Microbiology, Washington, 
DC. 45-77. 
Weingarten, R., L. Ransniis, H. Mueller, L. A. Sklar, and G. M. Bokoch. 
1980. Mastoparan i teracts with the carboxyl terminus of the a subunit of 
Gi. J. Biol. Chem. 265:11044-11049. 
Yokokawa, N., M. Komatsu, T. Takeda, T. Aizawa, and T. Yamada. 1989. 
Mastoparan, a wasp venom, stimulates insulin release by pancreatic islets 
through pertussis toxin sensitive GTP-binding protein. Biochem. Biophys. 
ICes. Commun. 158:712-716. 
Zachary, I., J. W. Sinnett-Smith, and E. Rozengurt. 1986. Early events elicited 
by bombesin and structurally related peptides in quiescent Swiss 3T3 ceils. 
I. Activation of protein kinase C and inhibition of epidermal growth factor 
binding. J. Cell Biol. 102:2211-2222. 
Zachary, I., J. Millar, E. N~nberg, T. Higgins, and E. Rozengurt. 1987. Inhi- 
bition of bombesin-induced mitogenesis bypertussis toxin: dissociation from 
phospholipase C pathway. Biochem. Biophys. Res. Commun. 146:456-463. 
The Journal of Cell Biology, Volume 113, 1991 950 
 o
n
 M
ay 8, 2012
jcb.rupress.org
D
ow
nloaded from
 
Published May 15, 1991
